Publicaciones
-
Crompton BD, Stewart C, Taylor-Weiner A, Alexe G, Kurek KC, Calicchio ML, Kiezun A, Carter SL, Shukla SA, Mehta SS, Thorner AR, de Torres C, Lavarino C, Suñol M, McKenna A, Sivachenko A, Cibulskis K, Lawrence MS, Stojanov P, Rosenberg M, Ambrogio L, Auclair D, Seepo S, Blumenstiel B, DeFelice M, Imaz-Rosshandler I, Schwarz-Cruz Y Celis A, Rivera MN, Rodriguez-Galindo C, Fleming MD, Golub TR, Getz G, Mora J and Stegmaier K.
The Genomic Landscape of Pediatric Ewing Sarcoma
CANCER DISCOVERY . 4(11): 1326-1341. Nº de citas: 407
-
Shih DJ, Northcott PA, Remke M, Korshunov A, Ramaswamy V, Kool M, Luu B, Yao Y, Wang X, Dubuc AM, Garzia L, Peacock J, Mack SC, Wu X, Rolider A, Morrissy AS, Cavalli FM, Jones DT, Zitterbart K, Faria CC, Schüller U, Kren L, Kumabe T, Tominaga T, Shin Ra Y, Garami M, Hauser P, Chan JA, Robinson S, Bognár L, Klekner A, Saad AG, Liau LM, Albrecht S, Fontebasso A, Cinalli G, De Antonellis P, Zollo M, Cooper MK, Thompson RC, Bailey S, Lindsey JC, Di Rocco C, Massimi L, Michiels EM, Scherer SW, Phillips JJ, Gupta N, Fan X, Muraszko KM, Vibhakar R, Eberhart CG, Fouladi M, Lach B, Jung S, Wechsler-Reya RJ, Fèvre-Montange M, Jouvet A, Jabado N, Pollack IF, Weiss WA, Lee JY, Cho BK, Kim SK, Wang KC, Leonard JR, Rubin JB, de Torres C, Lavarino C, Mora J, Cho YJ, Tabori U, Olson JM, Gajjar A, Packer RJ, Rutkowski S, Pomeroy SL, French PJ, Kloosterhof NK, Kros JM, Van Meir EG, Clifford SC, Bourdeaut F, Delattre O, Doz FF, Hawkins CE, Malkin D, Grajkowska WA, Perek-Polnik M, Bouffet E, Rutka JT, Pfister SM and Taylor MD.
Cytogenetic Prognostication Within Medulloblastoma Subgroups
JOURNAL OF CLINICAL ONCOLOGY . 32(9): 886-886. Nº de citas: 235
-
Rabadán MA, Usieto S, Lavarino C and Martí E.
Identification of a Putative Transcriptome Signature Common to Neuroblastoma and Neural Crest Cells
DEVELOPMENTAL NEUROBIOLOGY . 73(11): 815-827. Nº de citas: 13
-
Masvidal L, Iniesta R, Casalà C, Galván P, Rodriguez E, Lavarino C, Mora J and de Torres C.
Polymorphisms in the Calcium-Sensing Receptor Gene Are Associated with Clinical Outcome of Neuroblastoma
PLoS One . 8(3): . Nº de citas: 14
-
Casalà C, Gil-Guiñón E, Ordóñez JL, Miguel-Queralt S, Rodriguez E, Galván P, Lavarino C, Munell F, de Alava E, Mora J and de Torres C.
The calcium-sensing receptor is silenced by genetic and epigenetic mechanisms in unfavorable neuroblastomas and its reactivation induces ERK1/2-dependent apoptosis
Carcinogenesis . 34(2): 268-276. Nº de citas: 38
-
Mayol G, Martín-Subero JI, Ríos J, Queiros A, Kulis M, Suñol M, Esteller M, Gomez-Gonzalez S, Garcia I, de Torres C, Rodriguez E, Galván P, Mora J and Lavarino C.
DNA Hypomethylation Affects Cancer-Related Biological Functions and Genes Relevant in Neuroblastoma Pathogenesis
PLoS One . 7(11): . Nº de citas: 36
-
Morales-La Madrid A, Volchenboum S, Gastier-Foster JM, Pyatt R, Liu D, Pytel P, Lavarino C, Rodriguez E and Cohn SL.
Locoregional MYCN-amplified neuroblastoma
PEDIATRIC BLOOD & CANCER . 59(4): 736-738.
-
Garcia I, Mayol G, Ríos J, Domenech G, Cheung NK, Oberthuer A, Fischer M, Maris JM, Brodeur GM, Hero B, Rodriguez E, Suñol M, Galvan P, de Torres C, Mora J and Lavarino C.
A Three-Gene Expression Signature Model for Risk Stratification of Patients with Neuroblastoma
CLINICAL CANCER RESEARCH . 18(7): 2012-2023. Nº de citas: 55
-
Acosta S, Mayol G, Rodriguez E, Lavarino C, de Preter K, Kumps C, Garcia I, de Torres C and Mora J.
Identification of tumoral glial precursor cells in neuroblastoma
CANCER LETTERS . 312(1): 73-81. Nº de citas: 13
-
Garcia I, Mayol G, Rodriguez E, Suñol M, Gershon TR, Ríos J, Cheung NK, Kieran MW, George RE, Perez-Atayde AR, Casalà C, Galván P, de Torres C, Mora J and Lavarino C.
Expression of the neuron-specific protein CHD5 is an independent marker of outcome in neuroblastoma
MOLECULAR CANCER . 9: 277-277. Nº de citas: 58
